The European Alliance for Access to Safe Medicines (EAASM) welcomes the revision of the EU general pharmaceuticals legislation and with a view to protect patient safety and enhance scientific and technological developments in Europe, it is firmly resolved to significantly reduce medication errors and promote, at European and national levels, the implementation of comprehensive electronic traceability systems in…
EAA
European Alliance for Access to Safe Medicines
NGO · United Kingdom · EU Transparency Register 861368611058-84
2
positions filed
in the 583 files tracked
1
legislative file
of 583 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 964 non-governmental organisations on this site, they rank #586 by legislative files engaged — a count of participation, not a measure of influence.
0.5
declared lobbying FTE
self-declared
—
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2013
in the register since
Declares membership of
- The EAASM is an active member of the Alliance for Safe Online Pharmacy in the EU (ASOP EU) Community Interest Company…
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026).
- Register category
- Non-governmental organisations
- Head office
- Leigh on Sea, United kingdom
- EU office
- Tunbridge Wells
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track European in PolicySpeak: request access →
Work at European Alliance for Access to Safe Medicines? so we know who speaks for it.
Their record over time
European Alliance for Access to Safe Medicines filed 2 positions between 22 Apr 2021 and 26 Apr 2021, across 1 of the 583 legislative files tracked here, attaching a full position paper 1 time.
What they argued
The European Alliance for Access to Safe Medicines (EAASM) welcomes the revision of the EU general pharmaceuticals legislation and with a view to foster innovation and protect patient safety across Europe, including in areas of unmet medical need, the EAASM stresses the importance of establishing a fit for purpose regulatory framework for nanomedicines at the EU level.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put European Alliance for Access to Safe Medicines next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from European Alliance for Access to Safe Medicines’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.